SCHEMBL65584

SCHEMBL65584

N#Cc1cccn1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18886839 0.75 MAP4K4 (0.35) —
SCHEMBL11707680 0.72 — —
SCHEMBL28309527 0.72 — —
SCHEMBL27739596 0.72 — —
SCHEMBL5081060 0.72 — —
SCHEMBL19491720 0.72 — —
SCHEMBL27977646 0.72 — —
SCHEMBL3934072 0.72 — —
SCHEMBL27592302 0.69 PARP1 (0.36) —
SCHEMBL7072277 0.69 GLA (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120158224-A Protective coating with stealth function and preparation method thereof 蓝箭航天材料(开化)有限公司 2025-06-17 — — CN claimed
CN-120158224-A Protective coating with stealth function and preparation method thereof 蓝箭航天材料(开化)有限公司 2025-06-17 — — CN disclosed
WO-2024245115-A1 PREPARATION METHOD FOR PYRROLOTRIAZINE COMPOUND 临海市华南化工有限公司 2024-12-05 — — WO disclosed
CN-113480548-B Preparation method of 4-aminopyrrolo [2,1-f ] [1,2,4] triazine 山东三牧新材料科技有限公司 2023-09-22 — — CN disclosed
CN-113480548-A Preparation method of 4-aminopyrrolo [2,1-f ] [1,2,4] triazine 山东三牧新材料科技有限公司 2021-10-08 — — CN disclosed
WO-2019149114-A1 PREPARATION AND USE OF COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OR COMPOSITION THEREOF 深圳铂立健医药有限公司 2019-08-08 — — WO disclosed
CN-104003990-B Heterocyclic amine Hedgehog signal pathway inhibitors 江苏先声药业有限公司 2017-09-15 — — CN disclosed
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 — — EP disclosed
US-9718828-B2 BTK Inhibitors MERCK SHARP & DOHME CORP. (US) 2017-08-01 — — US disclosed
US-20170008899-A1 BTK INHIBITORS MERCK SHARP & DOHME CORP. (US) 2017-01-12 — — US disclosed
US-7223766-B2 Bi-cyclic pyrimidine inhibitors of TGFβ SCIOS, INC. (US) 2007-05-29 — — US disclosed
US-7223766-B2 Bi-cyclic pyrimidine inhibitors of TGFβ SCIOS, INC. (US) 2007-05-29 — — US disclosed
WO-2007056170-A2 PYRROLO[2,1-F] [1,2,4] TRIAZIN-4-YLAMINES IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2007-05-18 — — WO disclosed
US-20070112005-A1 mammalian Target Of Rapamycin (mTOR) kinase; for treatment of lymphoma or ovarian cancer OSI PHARMACEUTICALS, INC. 2007-05-17 — — US disclosed
US-20070032512-A1 6,6-Bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS, INC., 2007-02-08 — — US disclosed
US-20060235031-A1 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors ACERTA PHARMA B.V. (NL) 2006-10-19 — — US disclosed
WO-2006035061-A1 HCV INHIBITING BI-CYCLIC PYRIMIDINES TIBOTEC PHARMACEUTICALS LTD. (IE) 2006-04-06 — — WO disclosed
EP-1183033-B1 PYRROLOTRIAZINE INHIBITORS OF KINASES BRISTOL MYERS SQUIBB CO (US) 2006-03-01 — — EP disclosed
US-20050004143-A1 Bi-cyclic pyrimidine inhibitors of TGFbeta SCIOS, INC. 2005-01-06 — — US disclosed
EP-0061056-A1 5,6-Dimethylpyrrolo (2,3-b) pyridines, process for their preparation and their use as medicaments Troponwerke GmbH &amp; Co. KG (DE) 1982-09-29 — — EP disclosed
Send feedback